
Vallexa Advisors Works Nationwide from
Our Two Locations in
Detroit, Michigan and Las Vegas, Nevada
Our Leadership Team can be reached even when out of the office,
so please do not hesitate to share your questions with us.
We are always happy to help.
Email us at: info@vallexa.com
FAQ
How quickly will someone respond to my inquiry?
For confidential inquiries submitted through the contact form, an advisor will typically be in touch within 24 hours.
Can I reach someone even if it’s after hours?
Yes. The page notes that Vallexa’s leadership team can be reached even when out of the office, so you can still send your question and they’ll follow up.
What’s the best way to contact Vallexa Advisors?
You can call the main line 586-623-5616 or email Info@Vallexa.com.
Where are you located, and do you work nationwide?
Vallexa Advisors works nationwide, with two locations in Detroit, Michigan and Las Vegas, Nevada.
What types of businesses do you specialize in?
Vallexa Advisors focuses on healthcare M&A and commonly supports clients with home health valuation, hospice valuation, and healthcare business sales.
I’m a buyer. Do I need to sign an NDA before getting deal details?
In most cases, yes. Buyers are asked to authorize an NDA before receiving confidential information (such as a VDR or financials). After an NDA is authorized, Vallexa notes it is reviewed by their administrative team and the buyer is contacted within 1 business day with next steps.
I’m a seller. Can I start with a confidential consultation or valuation?
Yes, Vallexa invites owners to contact them to schedule a free consultation or business valuation (no obligation language is also used on the site).
What information should I include in the contact form to get the fastest response?
Include whichever applies:
-
Are you buying or selling?
-
State(s)/region you’re focused on
-
Business type (home health, hospice, home care, etc.)
-
If buying: ideal size range (revenue/EBITDA), timing, and whether you’re ready to sign an NDA
-
If selling: location, license/Medicare status, and whether you want a valuation/exit timeline